Navigation Links
TOX/See Drugscreen AMP1000

ProductsTOX/See Drugscreen AMP1000
Company Bio-Rad Laboratories
Item TOX/See Drugscreen AMP1000
Features 
  • ComprehensiveTests for as many as 9 drugs per cassette
  • EfficientOne-step test protocol
  • FastResults in as few as 3 minutes
Description TOX/See™ is a 1-step, hand-held, point-of-care device for the qualitative detection of drug or drug metabolites in human urine.

The TOX/See device can detect up to nine of the most commonly abused drugs in 3 to 8 minutes and requires only a few drops of urine. Each TOX/See cassette is individually packaged to maximize convenience and ease of use. TOX/See features integrated test controls, easy-to-read results, and an 18-month shelf life at room temperature. The completed test card can be photocopied and archived for health and legal records.

The straightforward test protocol is designed for use by all levels of staff in hospitals, emergency departments, correctional facilities, juvenile facilities, police departments, workplaces, and recovery and rehabilitation programs.

Info Bio-Rad Laboratories
Customer Service: 1-800-2-BIORAD
Web site: http://www.bio-rad.com

Related medicine products :

1. TOX/See Rapid Urine Drug Screen Tests
2. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MDMA/MET/MTD/OPI/PCP/THC)
3. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MET/MTD/OPI/PCP/TCA/THC)
4. TOX/See multi-Drugscreen Panel 9-test (PCP/BAR/AMP1000/COC/MET1000/TCA/MOR300/THC/BZO)
5. TOX/See multi-Drugscreen Panel 10-test (AMP/BAR/BZO/COC/MDMA/MET/MTD/OPI/TCA/THC)
6. TOX/See multi-Drugscreen Panel 8-test (AMP1000/COC/MOR300/THC/BZO/MET1000/MTD/BAR)
7. TOX/See multi-Drugscreen Panel 8-test (THC/COC/AMP1000/PCP/BAR/BZO/MOR2000/MTD)
8. TOX/See multi-Drugscreen Panel 8-test (THC/COC/AMP1000/PCP/BAR/BZO/MOR300/MTD)
9. TOX/See multi-Drugscreen Panel 5-test THC/MOR300/AMP1000/COC/BZO
10. TOX/See multi-Drugscreen Panel 5-test THC/COC/PCP/MOR300/AMP1000
11. TOX/See multi-Drugscreen Panel 5-test THC/COC/MOR300/AMP1000/MET1000
Utilized for capsulotomies, nucleus dislocating, and other intraocular applications. Formed (bent) cystitomes are angled to conform to the convexity of the lens, providing easier access to the anteri
Left. 23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 20 degree shaft 10 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Side taper irrigation-aspiration th
This specially designed 23 gauge spoon-shaped cannula is connected to a balanced salt solution bottle and with a low-flow of fluid, is designed to allow a controlled cleaning of the stromal interface
Reliance pneumatic stools come with five legs for extra stability. Adjustable height range of 18" to 25" (total vertical travel 6"). 2" ball bearing swivel hard rubber castors. Comfortable, durable a
Medicine Products:
(Date:12/3/2008)...ber 3, 2008 (BRONX, NY) A new study led by resea...eshiva University has clarified how two major vari...logic complications. The finding, published in J...or drugs that could prevent HIV-associated dementi...on in people with AIDS. Even with anti-retroviral ...
(Date:12/3/2008)...who had aggressive surgeries were free of tumor re..., , ROCHESTER, Minn., Dec. 3 /PRNewswire-USN...ients with low-grade gliomas survived longest when...ly remove the entire tumor. If safely removing the...significantly longer when surgery was followed by ...
(Date:12/3/2008)... N.J., Dec. 3 Memory Pha...ced that, on December 3, 2008, the Company,receiv...ions Panel (the,"Panel") that the Panel has deter... NASDAQ Capital Market. However, the Company was ...earing Review Council (the "Review Council") has,...
(Date:12/3/2008)...To Three and Half Times Greater Than Entire U.S. E...swire/ -- If the federal government stopped the Me...llecting no more payroll taxes and allowing no mor...$52 trillion to those who have already earned thes...al Center for Policy Analysis (NCPA). , , ...
Breaking Medicine News(10 mins):Health News:Study sheds light on causes of HIV dementia 2Health News:Study sheds light on causes of HIV dementia 3Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 2Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 3Health News:Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers 2
... the Revised National TB Control Programme (RNTCP)...ized//, good quality treatment and diagnostic serv...t about 50 - 60 % of HIV-positive people are more ...n Health and Family Welfare Minister Anbumani Rama...
...o the study conducted by Steven M. Kurtz, of Expon...entific consulting firm//, there is an increase in...the number of artificial joints needed to replace ...ar by 2030. The study showed that the demand for a...
...iet and products had captured the market and minds... medical scrutiny. // A number of detox products ...This follows a report by the BBC which drew its at...cal claims. The Medical Health Care Products Regu...
...inister of Bihar, Nitish Kumar assured that the Bi...ting the alarming spread of AIDS/HIV in the state ...he Udayan Sharma foundation, Samyak and the Nation... Expressing concern over the explosive prevalence...
Other Medicine News:Health News:India to Implement National Action Plan against TB-HIV 2
(Date:12/1/2008)...DIEGO, Dec. 1 Vical Inco...eipt of a $1.0 million milestone payment from Merc...ion of a Phase I clinical trial of an investigatio...te vaccine is based on Vical,s DNA gene delivery t...nscriptase (hTERT). hTERT is the subject of separa...
(Date:11/28/2008)...GÿRLITZ, Germany, November 28 Ger...l leadership in specialized HIV monitoring and,AI...d emerging countries. In,the year 2008, 2.5 milli...table, robust and highly affordable "CyFlow" syste...living with HIV/AIDS. Due to introduction of the,...
(Date:11/26/2008)...ESTER, Minn., Nov. 26 C...d are at significantly increased risk of developin...findings of a Mayo Clinic study published this mo...erican Academy of Pediatrics. , , The retro... patients with strabismus (misaligned eyes) and co...
(Date:11/25/2008)...tom awareness can improve recovery , , Audi...are available on the Mayo Clinic News Blog. Please..., , ROCHESTER, Minn., Nov. 25 /PRNewswire-U... of stroke patients don,t think they,re having a s...t until their condition worsens. The findings appe...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 1Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 2Researchers find gene location that gives rise to neuroblastoma an aggressive childhood cancer 18719 3MIT study suggests caution on new anti obesity drug in kids 18717 1MIT study suggests caution on new anti obesity drug in kids 18717 2Patients with chronic illness benefit from telehealth intervention 18715 1Patients with chronic illness benefit from telehealth intervention 18715 2The FAQs about the human genome 3230 1
.../PRNewswire-FirstCall/ - YM,BioSciences Inc. , an ...mercializes differentiated products for patients w...y investigators from Kinki,University School of Me... The Japanese Association for Molecular Target The... the increased,radiosensitivity of human NSCLC cel...
...USINESS WIRE)--Jul 9, 2007 -,Icagen, Inc. (NASDAQ:... Chief Executive Officer, will present at the C.E....onference in New York City on,Thursday, July 12th ...this presentation from the,conference. The webcast...nvestor relations section of the Icagen website at...
Other Medicine Technology:YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 2YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 3YM BioSciences Announces Preclinical Data Confirming Nimotuzumab,Binds to the EGF Receptor and Potentiates Radiotherapy 4Icagen to Present at the C.E. Unterberg, Towbin Emerging Growth,Opportunities Conference 2